rs104893823
|
|
|
0.040 |
GeneticVariation |
BEFREE |
Mutations in cardiac troponin C (D75Y, E59D, and G159D), a key regulatory protein of myofilament contraction, have been associated with dilated cardiomyopathy (DCM).
|
27133568 |
2016 |
rs104893823
|
|
|
0.040 |
GeneticVariation |
BEFREE |
The dilated cardiomyopathy G159D mutation in cardiac troponin C weakens the anchoring interaction with troponin I.
|
18803402 |
2008 |
rs104893823
|
|
|
0.040 |
GeneticVariation |
BEFREE |
Dilated cardiomyopathy (DCM) can be caused by a Gly159Asp mutation in cardiac troponin C (cTnC).
|
17577574 |
2007 |
rs104893823
|
|
|
0.040 |
GeneticVariation |
BEFREE |
We investigated the effect of the dilated cardiomyopathy linked cTnC Gly159 to Asp (cTnC-G159D) mutation on the development of Ca(2+)-dependent tension and ATPase rate in whole troponin-exchanged skinned rat trabeculae.
|
17446435 |
2007 |
rs104894501
|
|
|
0.040 |
GeneticVariation |
BEFREE |
The Glu40Lys and Glu54Lys mutations in alpha-tropomyosin cause dilated cardiomyopathy (DCM).
|
19222994 |
2009 |
rs104894501
|
|
|
0.040 |
GeneticVariation |
BEFREE |
E40K and E54K mutations in alpha-tropomyosin cause inherited dilated cardiomyopathy.
|
17360712 |
2007 |
rs104894501
|
|
|
0.040 |
GeneticVariation |
BEFREE |
In order to understand how the dilated cardiomyopathy-causing Glu40Lys mutation in TM affects actomyosin interactions, thin filaments have been reconstituted in muscle ghost fibers by incorporation of labeled Cys707 of myosin subfragment-1 and Cys374 of actin with fluorescent probe 1.5-IAEDANS and α-tropomyosin (wild-type or Glu40Lys mutant).
|
21741356 |
2011 |
rs104894501
|
|
|
0.040 |
GeneticVariation |
BEFREE |
Five Tm mutations were chosen for this study: the hypertrophic cardiomyopathy (HCM) mutations E62Q, E180G, and L185R and the dilated cardiomyopathy (DCM) mutations E40K and E54K.
|
16043485 |
2005 |
rs104894505
|
|
|
0.040 |
GeneticVariation |
BEFREE |
The effect of the dilated cardiomyopathy-causing mutation Glu54Lys of alpha-tropomyosin on actin-myosin interactions during the ATPase cycle.
|
19646950 |
2009 |
rs104894505
|
|
|
0.040 |
GeneticVariation |
BEFREE |
The Glu40Lys and Glu54Lys mutations in alpha-tropomyosin cause dilated cardiomyopathy (DCM).
|
19222994 |
2009 |
rs104894505
|
|
|
0.040 |
GeneticVariation |
BEFREE |
Five Tm mutations were chosen for this study: the hypertrophic cardiomyopathy (HCM) mutations E62Q, E180G, and L185R and the dilated cardiomyopathy (DCM) mutations E40K and E54K.
|
16043485 |
2005 |
rs104894505
|
|
|
0.040 |
GeneticVariation |
BEFREE |
E40K and E54K mutations in alpha-tropomyosin cause inherited dilated cardiomyopathy.
|
17360712 |
2007 |
rs104894655
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethonin.
|
10655062 |
2000 |
rs104894942
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Patient with c.280C>T mutation had dilated cardiomyopathy, while another patient with c.39_60del mutation had no feature of cardiomyopathy.
|
28123175 |
2017 |
rs1064793814
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Truncations of titin causing dilated cardiomyopathy.
|
22335739 |
2012 |
rs10859313
|
|
A |
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy.
|
23853074 |
2014 |
rs10927875
|
|
|
0.800 |
GeneticVariation |
GWASCAT |
A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy.
|
21459883 |
2011 |
rs10927875
|
|
|
0.800 |
GeneticVariation |
GWASDB |
A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy.
|
21459883 |
2011 |
rs111033559
|
|
T |
0.710 |
CausalMutation |
CLINVAR |
Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban.
|
12610310 |
2003 |
rs111033559
|
|
T |
0.710 |
CausalMutation |
CLINVAR |
A study in Polish patients with cardiomyopathy emphasizes pathogenicity of phospholamban (PLN) mutations at amino acid position 9 and low penetrance of heterozygous null PLN mutations.
|
25928149 |
2015 |
rs111033559
|
|
T |
0.710 |
CausalMutation |
CLINVAR |
Comparative proteomics profiling of a phospholamban mutant mouse model of dilated cardiomyopathy reveals progressive intracellular stress responses.
|
18056057 |
2008 |
rs111033559
|
|
T |
0.710 |
CausalMutation |
CLINVAR |
Structure-function relation of phospholamban: modulation of channel activity as a potential regulator of SERCA activity.
|
23308118 |
2013 |
rs111033559
|
|
T |
0.710 |
CausalMutation |
CLINVAR |
Hydrophobic imbalance in the cytoplasmic domain of phospholamban is a determinant for lethal dilated cardiomyopathy.
|
22427649 |
2012 |
rs111033559
|
|
|
0.710 |
GeneticVariation |
BEFREE |
A mouse line with heterozygous transgenic expression of phospholamban carrying a substitution of cysteine for arginine 9 (TgPLN<sup>R9C</sup>) under the control of α-myosin heavy chain (αMHC) promoter features dilated cardiomyopathy, heart failure, and premature death.
|
29325795 |
2018 |
rs111033559
|
|
T |
0.710 |
CausalMutation |
CLINVAR |
Acute inotropic and lusitropic effects of cardiomyopathic R9C mutation of phospholamban.
|
25593317 |
2015 |